About Tenshi Life Sciences
Tenshi Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2007 by Pudhucode Radhakrishnan Kannan. It delivers advanced finished dosage pharmaceuticals using global infrastructure and quality systems. It operates on a B2B and Licensing model. The company has 161 employees. Tenshi Life Sciences has completed 1 acquisition, including Naari. Its Indian entity Instapill Private Limited reported revenue of ₹101 Cr. Tenshi Life Sciences offers products and services including InstaPill Rapid Dissolve Tabs. Its focus areas include Health and Pharmaceuticals, Bio Pharmaceuticals, Niche Generics and Rapid Dissolve Tabs. Its competitors include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma and 5 more; 4 of its 10 listed competitors have raised funding.
Company details
Tenshi Kaizen focuses on producing reliable, cost-effective pharmaceutical products through proprietary technology and a global network. The company operates from Bangalore, India, emphasizing speed and agility in manufacturing. It caters to world markets by anticipating needs and exploring new commercial opportunities in sectors like bio pharmaceuticals and niche generics. Activities include in-licensing and supply chain management to meet international demands.
- Headquarters Bengaluru, India
- Employees 161
- Founders Pudhucode Radhakrishnan Kannan
- SectorsHealthcare
- Email••••••••
- Website tenshi.co.in
- Legal Name Tenshi Kaizen Pvt. Ltd
- Date of Incorporation 02 Apr, 2007
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹101 Cr
FY 2025 · +11% YoY
- Net Loss-₹83.70 Cr
FY 2025 · -83% margin
- EBITDA-₹24.31 Cr
FY 2025 · -24% margin
- Employee Count161
- Investments & Acquisitions
Associated legal entities of Tenshi Life Sciences
Tenshi Life Sciences is associated with 9 registered companies on The Company Check; the primary company is Instapill Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Instapill Private Limited CIN U24230KA2007PTC042337 | Active | 02 Apr 2007 | Bangalore, Karnataka | ₹101 Cr | 161 | 7 | View details |
| Six Rays Llp CIN AAW-2371 | Active | 09 Mar 2021 | Bangalore, Karnataka | – | 3 | 2 | View details |
| Tenshi Ksm Private Limited CIN U24299KA2019PTC121725 | Dissolved Under Section 59(8) | 21 Feb 2019 | Bangalore, Karnataka | ₹0.2 Cr | – | 2 | View details |
| Chayadeep Properties Private Limited CIN U45203KA2003PTC094179 | Active | 16 Jun 2003 | Bangalore, Karnataka | ₹16.7 Cr | – | 2 | View details |
| Tenshi Healthcare Private Limited CIN U74999TN2018PTC125505 | Strike Off | 29 Oct 2018 | Chennai, Tamil Nadu | – | – | 2 | View details |
| Tenshi Pharmaceuticals Private Limited CIN U74999KA2016PTC200180 | Active | 01 Jul 2016 | Bangalore, Karnataka, India | $67.3M | – | – | View details |
| Tenshi Life Sciences Private Limited CIN U74110TN2016PTC126537 | Amalgamated | 28 Jul 2016 | Chennai, Tamil Nadu, India | $2.0M | – | – | View details |
| Velbiom Probiotics Private Limited CIN U24230KA2015PTC083357 | Active | 12 Oct 2015 | Bengaluru, Karnataka, India | – | – | – | View details |
| Tenshi Pharmaceuticals Private Limited CIN U70200KA2016PTC200180 | Active | 01 Jul 2016 | Bangalore, Karnataka | ₹41.7 Cr | 8 | 2 | View details |
Products & Services of Tenshi Life Sciences
Tenshi Life Sciences offers a comprehensive portfolio of products and services, including InstaPill Rapid Dissolve Tabs.
Provides rapid dissolve tabs for advanced dosage delivery in health applications.
Board of directors of Instapill Private Limited (Tenshi Life Sciences)
Instapill Private Limited is the primary company behind Tenshi Life Sciences. The boards of the 6 registered companies of Tenshi Life Sciences currently have 11 directors; the longest-serving is Venkataraman Subramanian Iyer, appointed in 2007. 40 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkataraman Subramanian Iyer DIN 00408092 | Director | 02 Apr 2007 | 19 yrs 6 mo | Instapill Private Limited |
| Nanditale Thimmappa Venkatesha DIN 07405779 | Director | 27 Feb 2017 | 9 yrs 7 mo | Chayadeep Properties Private Limited |
| Guruswamy Pendyala DIN 01880807 | Whole-time director | 28 Apr 2017 | 9 yrs 5 mo | Instapill Private Limited |
| Ramaprasad Jyothinagaravyasha Sriraman DIN 00173696 | Designated Partner | 09 Mar 2021 | 5 yrs 7 mo | Six Rays Llp, Tenshi Ksm Private Limited, Tenshi Healthcare Private Limited |
| Chandrappa Seetharamaiah DIN 07405773 | Designated Partner | 09 Mar 2021 | 5 yrs 7 mo | Six Rays Llp, Tenshi Ksm Private Limited, Tenshi Healthcare Private Limited |
| Shridhara Kela DIN 02592314 | Director | 03 Jun 2024 | 2 yrs 4 mo | Tenshi Pharmaceuticals Private Limited |
| Pudhucode Radhakrishnan Kannan DIN 03435209 | Director | 17 Jun 2024 | 2 yrs 4 mo | Tenshi Pharmaceuticals Private Limited |
| Ankit Gupta DIN 08015587 | Whole-time director | 11 Feb 2025 | 1 yr 8 mo | Instapill Private Limited |
| Rajashri Santosh Kumar Ojha DIN 07058128 | Director | 11 Feb 2025 | 1 yr 8 mo | Instapill Private Limited |
| Gopakumar Gopalan Nair DIN 00092637 | Director | 11 Feb 2025 | 1 yr 8 mo | Instapill Private Limited |
| Sabarinath Gopala Krishnan DIN 08479403 | Additional Director | 25 Mar 2026 | 6 mo | Chayadeep Properties Private Limited |
People of Tenshi Life Sciences
1 people are tracked at Tenshi Life Sciences (1 in leadership); the tracked headcount is 161.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership |
Complete people profiles for Tenshi Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Tenshi Life Sciences
Figures of Instapill Private Limited, the primary company behind Tenshi Life Sciences, for FY 2025. Revenue was ₹101 Cr (+11% year on year). Net loss was -₹83.70 Cr (-83% margin). EBITDA was -₹24.31 Cr (-24% margin). Revenue has grown at a compounded annual rate of +25% over three years and +91% over five years.
- ₹101 CrRevenue · FY 2025 · +11% YoY
- -₹83.70 CrNet loss · -83% margin
- -₹24.31 CrEBITDA · -24% margin
- ₹18.64 CrPaid-up capital
- 161Employees (provident fund records)
- +25%Revenue CAGR, 3 years
- +91%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Instapill Private Limited are on its company page.
Detailed financial statements for Tenshi Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tenshi Life Sciences
Tenshi Life Sciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Naari.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Women care medicines are manufactured by Naari in India. | naari.co | Noida, India | 2007 | May 2017 | •••• |
Complete acquisition details for Tenshi Life Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Tenshi Life Sciences
2 dated milestones of Tenshi Life Sciences across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Tenshi Life Sciences is founded.
- Acquisition Acquires Naari.
Competitors of Tenshi Life Sciences
Tenshi Life Sciences has 10 listed competitors in our database, 4 of them funded. They include Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| almacgroup.com | 2001 | Craigavon, United Kingdom | $338.8M | 2,109 | Integrated CDMO services for biopharma R&D and manufacturing are offered. | |
| indoco.com | 1947 | Mumbai, India | – | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | |
| concordbiotech.com | 2000 | Ahmedabad, India | – | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | |
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. | |
| aurobindo.com | 1986 | Hyderabad, India | – | 1,010 | Generic biocatalytic solutions are provided for pharmaceutical applications. | |
| asymchem.com | 1995 | Morrisville, United States | – | 48 | APIs and peptides are developed and manufactured by Asymchem. | |
| seqens.com | 2003 | Ecully, France | – | 44 | Contract manufacturing services for small molecules and peptides are provided. | |
| continuuspharma.com | 2012 | Woburn, United States | $7.73M | 47 | MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | |
| pharm-int.com | 1994 | Hunt Valley, United States | – | 248 | Pharmaceutical dosage forms are manufactured by this CDMO. | |
| aptuit.com | 2004 | Greenwich, United States | $14.23M | – | Contract research and development services for small molecules are offered. |
Detailed competitors of Tenshi Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Tenshi Life Sciences (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Tenshi Life Sciences
Complete news archive for Tenshi Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tenshi Life Sciences
Tenshi Life Sciences was founded in 2007.
Tenshi Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Tenshi Life Sciences has 161 employees.
The primary company behind Tenshi Life Sciences, Instapill Private Limited, reported revenue of ₹101 Cr for FY 2025, up 11% year on year.
Tenshi Kaizen focuses on producing reliable, cost-effective pharmaceutical products through proprietary technology and a global network. The company operates from Bangalore, India, emphasizing speed and agility in manufacturing. It caters to world markets by anticipating needs and exploring new commercial opportunities in sectors like bio pharmaceuticals and niche generics. Activities include in-licensing and supply chain management to meet international demands.
Tenshi Life Sciences's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Tenshi Life Sciences offers InstaPill Rapid Dissolve Tabs.
Tenshi Life Sciences has made 1 acquisition, including Naari.
Tenshi Life Sciences is associated with 6 legal entities: Instapill Private Limited, Six Rays Llp, Chayadeep Properties Private Limited and others.
The legal entities of Tenshi Life Sciences currently have 12 directors, including Ramaprasad Jyothinagaravyasha Sriraman, Chandrappa Seetharamaiah, Nanditale Thimmappa Venkatesha and others.